Skip to main content
. Author manuscript; available in PMC: 2010 Apr 8.
Published in final edited form as: Leukemia. 2009 Feb 12;23(7):1278–1287. doi: 10.1038/leu.2009.21

Table 1.

Patient characteristics (n=59).

Median Age (range) 11 (1.6-24)
Male / Female 36 / 23
Disease
 ALL 23
 AML 19
 CML/JMML 10
 MDS 5
 Other 2
Disease Status
 CR1 18
 CR2/CR3 20
 Stable/First chronic phase 12
 Relapse/Refractory 9
Donor
 Median age (range) 35 (19-55)
 Male / Female 31 / 28
Graft
 T-cell deplete 40
 Unmanipulated 19
Median cell dose (range)
 TNC (108/kg) 2.03 (0.02-8.5)
 CD34+ cell (106/kg) 5.12 (0.18-23.9)
 CD3+ cell (106/kg)
  T-cell deplete 1.52 (0.37-7.7)
  Unmanipulated 49.4 (19.1-100)